[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

2018-2023 Global Clinical Oncology Next Generation Sequencing (NGS) Market Report (Status and Outlook)

October 2018 | 150 pages | ID: 2A4210C7B9BEN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Clinical Oncology Next Generation Sequencing (NGS) market for 2018-2023.

NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.
The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.
Over the next five years, LPI(LP Information) projects that Clinical Oncology Next Generation Sequencing (NGS) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Clinical Oncology Next Generation Sequencing (NGS) market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
  • NGS Pre-Sequencing
  • Sequencing
  • Primary, Secondary & Tertiary Data Analysis
Segmentation by application:
  • Academic & Clinical Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
We can also provide the customized separate regional or country-level reports, for the following regions:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • Illumina
  • Roche
  • Agilent Technologies
  • Knome
  • Genomatix Software
  • GATC Biotech
  • Oxford Nanopore Technologies
  • Macrogen
  • Life Technologies
  • DNASTAR
  • Exosome Diagnostics
  • Biomatters
  • CLC Bio
  • BGI
  • Qiagen
  • Perkin Elmer
  • Pacific Bioscience
  • Partek
  • GnuBIO
  • Foundation Medicine
  • Paradigm
  • Caris Life Sciences
  • Myriad Genetics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Clinical Oncology Next Generation Sequencing (NGS) market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Clinical Oncology Next Generation Sequencing (NGS) market by identifying its various subsegments.
  • Focuses on the key global Clinical Oncology Next Generation Sequencing (NGS) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Clinical Oncology Next Generation Sequencing (NGS) with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the size of Clinical Oncology Next Generation Sequencing (NGS) submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size 2013-2023
  2.1.2 Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Region
2.2 Clinical Oncology Next Generation Sequencing (NGS) Segment by Type
  2.2.1 NGS Pre-Sequencing
  2.2.2 Sequencing
  2.2.3 NGS Data Analysis
  2.2.4 Primary, Secondary & Tertiary Data Analysis
2.3 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
  2.3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
  2.3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type (2013-2018)
2.4 Clinical Oncology Next Generation Sequencing (NGS) Segment by Application
  2.4.1 Academic & Clinical Research
  2.4.2 Hospitals & Clinics
  2.4.3 Pharma & Biotech Entities
2.5 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
  2.5.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
  2.5.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Application (2013-2018)

3 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) BY PLAYERS

3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Players
  3.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Players (2016-2018)
  3.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Players (2016-2018)
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) BY REGIONS

4.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions
4.2 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth
4.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth
4.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth
4.5 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth

5 AMERICAS

5.1 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Countries
5.2 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
5.3 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Countries
6.2 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
6.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Clinical Oncology Next Generation Sequencing (NGS) by Countries
7.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
7.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) by Countries
8.2 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
8.3 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST

10.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2018-2023)
10.2 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Regions
  10.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Type
10.8 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Illumina
  11.1.1 Company Details
  11.1.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
  11.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Illumina News
11.2 Roche
  11.2.1 Company Details
  11.2.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
  11.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Roche News
11.3 Agilent Technologies
  11.3.1 Company Details
  11.3.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
  11.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Agilent Technologies News
11.4 Knome
  11.4.1 Company Details
  11.4.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
  11.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Knome News
11.5 Genomatix Software
  11.5.1 Company Details
  11.5.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
  11.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Genomatix Software News
11.6 GATC Biotech
  11.6.1 Company Details
  11.6.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
  11.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 GATC Biotech News
11.7 Oxford Nanopore Technologies
  11.7.1 Company Details
  11.7.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
  11.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Oxford Nanopore Technologies News
11.8 Macrogen
  11.8.1 Company Details
  11.8.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
  11.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Macrogen News
11.9 Life Technologies
  11.9.1 Company Details
  11.9.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
  11.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Life Technologies News
11.10 DNASTAR
  11.10.1 Company Details
  11.10.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
  11.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 DNASTAR News
11.11 Exosome Diagnostics
11.12 Biomatters
11.13 CLC Bio
11.14 BGI
11.15 Qiagen
11.16 Perkin Elmer
11.17 Pacific Bioscience
11.18 Partek
11.19 GnuBIO
11.20 Foundation Medicine
11.21 Paradigm
11.22 Caris Life Sciences
11.23 Myriad Genetics

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Table Product Specifications of Clinical Oncology Next Generation Sequencing (NGS)
Figure Clinical Oncology Next Generation Sequencing (NGS) Report Years Considered
Figure Market Research Methodology
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate 2013-2023 ($ Millions)
Table Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of NGS Pre-Sequencing
Table Major Players of Sequencing
Table Major Players of NGS Data Analysis
Table Major Players of Primary, Secondary & Tertiary Data Analysis
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
Figure Global NGS Pre-Sequencing Market Size Growth Rate
Figure Global Sequencing Market Size Growth Rate
Figure Global NGS Data Analysis Market Size Growth Rate
Figure Global Primary, Secondary & Tertiary Data Analysis Market Size Growth Rate
Figure Clinical Oncology Next Generation Sequencing (NGS) Consumed in Academic & Clinical Research
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market: Academic & Clinical Research (2013-2018) ($ Millions)
Figure Global Academic & Clinical Research YoY Growth ($ Millions)
Figure Clinical Oncology Next Generation Sequencing (NGS) Consumed in Hospitals & Clinics
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market: Hospitals & Clinics (2013-2018) ($ Millions)
Figure Global Hospitals & Clinics YoY Growth ($ Millions)
Figure Clinical Oncology Next Generation Sequencing (NGS) Consumed in Pharma & Biotech Entities
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market: Pharma & Biotech Entities (2013-2018) ($ Millions)
Figure Global Pharma & Biotech Entities YoY Growth ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2013-2018) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size in Academic & Clinical Research Growth Rate
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size in Hospitals & Clinics Growth Rate
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size in Pharma & Biotech Entities Growth Rate
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Players (2016-2018) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Players (2016-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Players in 2017
Table Global Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Products Offered
Table Clinical Oncology Next Generation Sequencing (NGS) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions 2013-2018 ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Regions 2013-2018
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Regions 2013-2018
Figure Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size 2013-2018 ($ Millions)
Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size 2013-2018 ($ Millions)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size 2013-2018 ($ Millions)
Table Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Countries (2013-2018) ($ Millions)
Table Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries (2013-2018)
Figure Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries in 2017
Table Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2013-2018) ($ Millions)
Table Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
Figure Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type in 2017
Table Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2013-2018) ($ Millions)
Table Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
Figure Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application in 2017
Figure United States Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Canada Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Table APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Countries (2013-2018) ($ Millions)
Table APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries (2013-2018)
Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries in 2017
Table APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2013-2018) ($ Millions)
Table APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type in 2017
Table APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2013-2018) ($ Millions)
Table APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application in 2017
Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Korea Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure India Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Australia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Countries (2013-2018) ($ Millions)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries (2013-2018)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries in 2017
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2013-2018) ($ Millions)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type in 2017
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2013-2018) ($ Millions)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application in 2017
Figure Germany Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure France Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure UK Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Italy Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Russia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Spain Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries in 2017
Table Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type in 2017
Table Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application in 2017
Figure Egypt Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Israel Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) arket Size Forecast (2018-2023) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share Forecast by Regions
Figure Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure United States Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Canada Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Brazil Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Korea Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure India Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Australia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Germany Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure France Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure UK Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Italy Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Russia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Spain Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Egypt Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure South Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Israel Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Turkey Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure GCC Countries Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share Forecast by Type (2018-2023)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share Forecast by Application (2018-2023)
Table Illumina Basic Information, Head Office, Major Market Areas and Its Competitors
Table Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Illumina Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Roche Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Agilent Technologies Basic Information, Head Office, Major Market Areas and Its Competitors
Table Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Knome Basic Information, Head Office, Major Market Areas and Its Competitors
Table Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Knome Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Genomatix Software Basic Information, Head Office, Major Market Areas and Its Competitors
Table Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table GATC Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Oxford Nanopore Technologies Basic Information, Head Office, Major Market Areas and Its Competitors
Table Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Macrogen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Macrogen Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Macrogen Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Life Technologies Basic Information, Head Office, Major Market Areas and Its Competitors
Table Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table DNASTAR Basic Information, Head Office, Major Market Areas and Its Competitors
Table DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Exosome Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biomatters Basic Information, Head Office, Major Market Areas and Its Competitors
Table CLC Bio Basic Information, Head Office, Major Market Areas and Its Competitors
Table BGI Basic Information, Head Office, Major Market Areas and Its Competitors
Table Qiagen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Perkin Elmer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pacific Bioscience Basic Information, Head Office, Major Market Areas and Its Competitors
Table Partek Basic Information, Head Office, Major Market Areas and Its Competitors
Table GnuBIO Basic Information, Head Office, Major Market Areas and Its Competitors
Table Foundation Medicine Basic Information, Head Office, Major Market Areas and Its Competitors
Table Paradigm Basic Information, Head Office, Major Market Areas and Its Competitors
Table Caris Life Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Myriad Genetics Basic Information, Head Office, Major Market Areas and Its Competitors

More Publications

Need Help?

Ask a Question

Market Reports

All Categories